CD4 and systemic lupus erythematosus: This led to a decrease in pro-inflammatory factors and an enhanced anti-inflammatory inhibitory effect on CD4+ T cells, ultimately mitigating the progression of systemic lupus erythematosus (SLE) in MRL/lpr mice (25).